7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 
      
                                                
      cash provided
                                                
      operating activities
                                                
      net income
    8,100,000 3,700,000 1,300,000 -21,400,000 -5,900,000 4,600,000 24,000,000 1,300,000 24,800,000 28,900,000 14,400,000 -33,200,000 -13,300,000 74,500,000 37,100,000 57,100,000 50,100,000 54,000,000 9,800,000 -12,800,000 -13,900,000 -15,300,000 -19,900,000 -105,200,000 -4,600,000 -4,400,000 4,200,000 -39,600,000 1,400,000 8,400,000 -1,900,000 -5,900,000 1,300,000 -5,300,000 -64,800,000 -16,600,000 -10,500,000 -13,600,000 -24,200,000 -30,800,000 -24,300,000 6,900,000 16,400,000 25,700,000 
      adjustments to reconcile net income to net cash provided (used) by operating activities:
                                                
      depreciation and amortization
    14,300,000 14,100,000 13,700,000 13,700,000 13,600,000 13,400,000 13,400,000 14,100,000 14,000,000 14,300,000 14,500,000 14,600,000 14,400,000 14,700,000 14,600,000 15,000,000 15,100,000 15,400,000 17,600,000 17,600,000 17,000,000 16,800,000 18,600,000 20,300,000 17,500,000 17,900,000 17,800,000 18,000,000 18,100,000 18,400,000 18,500,000 18,600,000 18,900,000 18,900,000 18,700,000 19,000,000 18,500,000 18,700,000 18,800,000 17,900,000 19,100,000 17,600,000 15,100,000 15,300,000 
      amortization of deferred financing fees
    100,000 100,000 100,000 100,000 200,000 100,000 100,000 100,000 100,000 200,000 100,000  200,000 200,000 200,000                              
      loss on extinguishment of debt
          11,400,000 100,000 26,000,000 17,000,000                              
      gain on sale or disposal of assets
    200,000 -1,500,000 200,000 100,000 200,000 100,000 300,000 -300,000 -2,600,000 100,000 -600,000 1,900,000 500,000 100,000 800,000 100,000      -2,300,000                   200,000   
      deferred income taxes
           -10,400,000 700,000 25,400,000 -300,000 -100,000 -100,000 1,300,000    -700,000 100,000 200,000 -14,300,000 -2,100,000 -200,000 500,000 600,000 -300,000 500,000 -100,000 300,000 -11,900,000 -9,800,000 -6,400,000 -8,700,000 -11,300,000 -18,200,000 -15,600,000 3,600,000 15,500,000 1,400,000 
      stock-based compensation expense
    3,800,000 3,700,000 3,400,000 3,500,000 3,500,000 3,500,000 3,500,000 3,000,000 3,000,000 2,900,000 2,600,000 2,300,000 2,200,000 2,200,000 2,100,000 1,800,000 1,900,000 1,800,000 1,800,000 1,400,000 1,600,000 1,600,000 2,000,000 2,200,000 1,400,000 1,600,000 2,200,000 1,400,000 2,200,000 1,500,000 2,200,000 1,500,000 1,800,000 1,600,000 2,100,000 1,600,000 1,500,000 1,500,000 1,000,000 1,200,000 2,800,000 2,000,000 1,700,000 2,300,000 
      pension and postretirement (benefit) expense
    800,000 1,000,000 800,000 9,300,000 1,000,000 2,100,000 2,000,000 40,700,000 600,000 2,000,000 3,800,000 4,200,000 5,100,000 -39,100,000 -10,700,000  -1,800,000 -5,200,000 -4,700,000                          
      changes in operating assets and liabilities:
                                                
      accounts receivable
    400,000 -3,700,000 -34,800,000 14,200,000 1,600,000 12,600,000 -6,700,000 22,700,000 -2,600,000 -6,000,000 -47,500,000 20,800,000 59,900,000 -25,000,000 -34,400,000 29,700,000 -8,900,000 -25,000,000 -33,000,000 17,900,000 -17,600,000 30,200,000 -16,300,000 29,900,000 39,000,000 4,900,000 12,100,000 8,700,000 1,500,000 7,500,000 -31,300,000 -7,100,000 -5,600,000 -56,300,000 12,300,000 -6,500,000 -2,400,000 -14,100,000       
      inventories
    -14,100,000 7,600,000 -10,800,000 -1,900,000 -14,500,000 33,000,000 -9,300,000 27,800,000 10,300,000 -21,000,000 -52,000,000 13,400,000 56,200,000 -31,800,000 -19,000,000 3,500,000 -9,400,000 -7,500,000 -28,200,000 -4,100,000 32,100,000 34,300,000 41,200,000 75,200,000 25,400,000 19,500,000 -27,500,000 -11,500,000 9,200,000 -41,700,000 -28,800,000 -20,200,000 -8,400,000 -26,700,000 -8,800,000 2,000,000 3,500,000 13,000,000 22,100,000 33,500,000 47,700,000 16,600,000 -20,700,000 -34,300,000 
      accounts payable
    5,300,000 -8,100,000 34,000,000 -2,800,000 -2,200,000 -30,700,000 16,500,000 -18,800,000 -14,900,000 -14,700,000 63,700,000 -13,300,000 -66,900,000 18,700,000 28,300,000 9,200,000 4,300,000 -8,100,000 48,100,000 14,900,000 25,400,000 -43,900,000 26,700,000 -6,100,000 -31,300,000 -19,600,000 -30,700,000 20,900,000          6,600,000       
      other accrued expenses
    7,300,000 5,300,000 2,900,000 -1,800,000 1,600,000 -17,300,000 -4,200,000 15,000,000 3,300,000 -200,000 -12,800,000 3,700,000 -2,000,000 9,600,000 -20,100,000 -600,000 5,000,000 7,700,000 -2,400,000 4,800,000 6,600,000 -7,700,000 5,700,000 -1,300,000 -2,400,000 -10,900,000 -11,400,000 2,100,000 7,000,000 300,000 -13,200,000 9,200,000 -1,400,000 2,900,000 200,000 5,500,000 -3,200,000 -10,700,000  -2,400,000 -100,000 -31,300,000  34,100,000 
      deferred charges and prepaid expenses
    -5,000,000 12,500,000 2,500,000 -12,100,000 -2,900,000 -5,900,000 1,300,000 1,100,000 -8,200,000 1,400,000 1,800,000 500,000 -3,600,000 200,000 300,000 1,200,000 -3,000,000 1,600,000 300,000 1,000,000 -3,100,000 1,700,000 -300,000 1,600,000 -2,300,000 800,000 100,000 1,200,000 -2,400,000 1,200,000 400,000 -2,400,000 1,300,000 -300,000 700,000 -2,100,000         
      pension and postretirement contributions and payments
    -500,000 -6,600,000 -53,000,000 -7,500,000 -3,400,000 -6,200,000 -28,400,000 -400,000 -500,000 -400,000 -1,500,000 -500,000 -900,000 -300,000 -3,700,000 -4,000,000 -900,000 -400,000 -1,600,000 100,000 -1,000,000 -700,000 -2,500,000 -1,500,000 1,200,000 -1,100,000 -2,400,000 -700,000 500,000 -10,400,000 -2,500,000 200,000 -1,100,000 -1,600,000  200,000 -1,400,000 -1,900,000 -3,400,000 -3,900,000 -3,100,000 -5,200,000 -5,400,000 -500,000 
      other
    500,000 1,600,000 2,500,000 10,500,000 -8,000,000 -1,100,000 21,100,000 -22,400,000 -1,500,000 8,500,000 10,500,000 -13,700,000 -6,200,000 400,000 1,600,000 4,400,000 -3,000,000 -1,100,000 -900,000 1,700,000 1,300,000 800,000 -800,000 -300,000 -900,000 3,000,000 2,700,000 -3,300,000 1,400,000 -1,500,000 1,500,000 -1,200,000 300,000 300,000 400,000 1,600,000 -1,200,000 -500,000 -1,600,000 11,600,000 -17,400,000 
      net cash provided (used) by operating activities
    22,000,000 34,800,000 -38,900,000 13,900,000 -15,300,000 8,300,000 33,400,000 74,100,000 28,100,000 13,300,000 9,800,000 23,700,000 46,800,000 50,700,000 13,300,000 90,700,000 53,800,000 39,200,000 13,200,000 52,500,000 41,100,000 16,100,000 63,800,000 46,000,000                     
      investing activities
                                                
      capital expenditures
    -28,400,000 -17,800,000 -27,500,000 -15,200,000 -17,600,000 -14,100,000 -17,400,000 -15,400,000 -17,500,000 -8,100,000 -10,600,000 -11,400,000 -5,700,000 -3,500,000 -6,500,000 -4,900,000 -3,500,000 -1,500,000 -2,300,000 -3,900,000 -3,400,000 -6,700,000 -2,900,000 -16,300,000 -9,400,000 -7,900,000 -4,400,000 -22,300,000 -8,700,000 -6,800,000 -2,200,000 -5,100,000 -4,100,000 -2,700,000 -16,600,000 -10,900,000 -6,700,000 -8,500,000 -25,300,000 -18,300,000 -16,700,000 -17,900,000 -46,500,000 -17,500,000 
      free cash flows
                                      2,300,000 -3,400,000 21,200,000 11,600,000 18,000,000 -16,700,000 30,900,000 -3,300,000 -21,100,000 -4,500,000 
      proceeds from government funding
    10,000,000 5,100,000 12,900,000 8,000,000 35,500,000                                        
      proceeds from disposals of property, plant and equipment
    1,700,000     200,000 1,500,000 2,400,000 2,900,000   1,000,000    900,000 1,600,000 600,000 7,800,000                    
      net cash provided (used) by investing activities
    -18,400,000 -12,700,000 -12,900,000 -7,200,000 17,900,000 -4,100,000 -17,400,000 -15,400,000 -17,500,000 -7,900,000 -9,100,000 -9,000,000 -2,800,000 -3,400,000 -6,500,000 -3,900,000 2,900,000 -1,500,000 -2,300,000 -3,000,000 -1,800,000 -6,100,000 4,900,000                      
      financing activities
                                                
      purchase of treasury shares
    -3,000,000 -3,300,000 -5,600,000 -3,500,000 -20,100,000 -9,600,000 -4,400,000 -4,100,000 -7,700,000 -11,400,000 -9,400,000 -19,600,000 -19,700,000 -9,300,000 -3,400,000                        -12,300,000 -300,000 -4,700,000 -30,600,000  
      proceeds from exercise of stock options
       100,000 200,000 1,100,000 400,000 600,000 500,000 1,300,000 100,000 100,000 1,500,000 6,300,000 800,000 100,000 700,000 2,500,000     200,000 100,000 100,000 200,000     200,000 200,000 1,100,000  
      shares surrendered for employee taxes on stock compensation
    -2,600,000 -100,000 -15,400,000 -3,400,000 -300,000 -100,000 -1,600,000 -500,000 -300,000 -100,000 -200,000 -1,000,000 -700,000 -200,000 -1,200,000           
      repayments on convertible notes
          -18,700,000 -40,800,000 -26,800,000                            
      net cash provided (used) by financing activities
    -3,000,000 -12,400,000 -8,200,000 -20,700,000 -20,100,000 -9,400,000 -18,700,000 -3,700,000 -7,100,000 -10,900,000 -30,200,000 -20,100,000 -20,300,000 -48,700,000 -25,500,000 800,000 100,000 -38,200,000 2,000,000 -21,500,000 -40,000,000 -100,000 -30,200,000 -21,000,000        -5,200,000 5,000,000 24,000,000         18,100,000 -1,700,000 
      increase in cash, cash equivalents, and restricted cash
    600,000 9,700,000 -60,000,000 -14,000,000 -17,500,000 -5,200,000 -2,700,000 55,000,000 3,500,000 -5,500,000 -29,500,000 -5,400,000 23,700,000 -1,400,000 -18,700,000                              
      cash, cash equivalents, and restricted cash at beginning of period
    241,900,000 281,300,000 257,800,000 259,600,000                              
      cash, cash equivalents, and restricted cash at end of period
    600,000 9,700,000 181,900,000 -14,000,000 -17,500,000 -5,200,000 278,600,000 55,000,000 3,500,000 -5,500,000 228,300,000 -5,400,000 23,700,000 -1,400,000 240,900,000                              
      the following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows:
                                                
      cash and cash equivalents
    700,000 10,500,000 180,300,000 -13,900,000 -18,200,000 -5,300,000 278,100,000 55,200,000 3,500,000 -5,500,000 227,400,000 -5,300,000 24,000,000 -1,400,000 239,900,000                              
      restricted cash reported in other current assets
    -100,000 -800,000 1,600,000 -100,000 700,000 100,000 500,000 -200,000 900,000 -100,000 -300,000 1,000,000                              
      total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows
    600,000 9,700,000 181,900,000 -14,000,000 -17,500,000 -5,200,000 278,600,000 55,000,000 3,500,000 -5,500,000 228,300,000 -5,400,000 23,700,000 -1,400,000 240,900,000                              
      debt issuance costs
               -300,000                                 
      loss on sale of consolidated subsidiary
                                               
      impairment charges
                   2,400,000 8,200,000                    500,000 400,000   
      proceeds from sale of consolidated subsidiary
                                               
      amortization of deferred financing fees and debt discount
                   300,000 200,000 200,000 300,000 1,300,000 1,300,000 1,400,000 1,300,000 1,400,000 1,200,000 1,200,000 1,300,000 1,200,000 1,300,000 1,200,000 1,800,000 1,000,000             
      repayments on credit agreements
                       -20,000,000 -40,000,000 -30,000,000 -20,000,000 -35,000,000 -5,000,000 -5,000,000                  
      pension and postretirement benefit
                          8,100,000 35,600,000 -400,000 4,600,000 1,800,000  -1,400,000 -1,500,000 -1,400,000              
      borrowings on credit agreements
                           10,000,000 30,000,000                  
      increase in cash and cash equivalents
                   87,600,000 56,800,000 -500,000 12,900,000 28,000,000 -700,000 9,900,000 38,500,000 8,700,000     -12,000,000 3,600,000 10,900,000 -10,400,000       11,600,000 -4,900,000   -3,000,000 -6,200,000 
      cash and cash equivalents at beginning of period
                   102,800,000 27,100,000 21,600,000 24,500,000 25,600,000 42,400,000 34,500,000   
      cash and cash equivalents at end of period
                   87,600,000 56,800,000 -500,000 115,700,000 28,000,000 -700,000 9,900,000 65,600,000 8,700,000 -2,500,000 13,100,000 7,800,000 -5,400,000 -12,000,000 3,600,000 35,400,000 -10,400,000 15,600,000 20,600,000 2,300,000 -13,900,000 -300,000 37,500,000 11,600,000 -4,900,000 4,700,000 31,000,000 -3,000,000 -6,200,000 
      impairment charges and (gain) loss on sale or disposal of assets
                                                
      refunding bonds repayments
                                                
      impairment charges and gain on sale or disposal of assets
                        200,000                        
      pension and postretirement expense
                        -5,900,000           3,000,000 800,000 800,000 62,200,000 7,000,000 7,600,000 6,600,000 7,800,000 7,800,000 6,500,000 8,600,000 5,300,000 5,900,000 
      impairment charges and loss on sale or disposal of assets
                           7,400,000 100,000                 
      net cash used by investing activities
                            -9,400,000 -7,900,000 -4,400,000 -22,300,000 -8,700,000 -5,800,000 -2,200,000 -5,100,000 -4,100,000 -2,700,000 -16,600,000 -10,900,000 -6,700,000 -8,500,000 -25,300,000 -18,200,000 -16,600,000 -17,700,000 -46,500,000 -17,500,000 
      adjustments to reconcile net income to net cash used by operating activities:
                                                
      net cash used by operating activities
                             16,000,000 -33,600,000  1,700,000 -10,700,000 -19,400,000              
      net cash from financing activities
                             5,000,000 24,200,000  -5,000,000 20,100,000 32,500,000              
      decrease (increase) in cash and cash equivalents
                             13,100,000 -13,800,000                  
      adjustments to reconcile net income to net cash from operating activities:
                                                
      effect of exchange rate changes on cash
                                                
      reimbursement from postretirement plan assets
                                      13,300,000       
      net cash from operating activities
                                      18,900,000 7,500,000 27,900,000 20,100,000 43,300,000 1,600,000 47,600,000 14,600,000 25,400,000 13,000,000 
      revenue refunding bonds repayments
                               -30,200,000              
      proceeds from issuance of convertible notes
                                              
      decrease in cash and cash equivalents
                                     -5,000,000    -4,900,000    -3,500,000   
      credit agreement repayments
                                -65,000,000    -10,000,000         
      amended credit agreement borrowings
                                25,000,000 130,000,000              
      amended credit agreement repayments
                                -5,000,000                
      debt issuance costs related to amended credit agreement
                                -1,700,000              
      accounts payable, trade
                                 6,800,000 35,700,000 3,000,000 4,400,000 39,400,000 13,900,000 500,000         
      net cash (used) provided by operating activities
                                   -100,000 14,700,000 -26,300,000           
      credit agreement borrowings
                                   5,000,000 25,000,000           
      amortization of deferred financing and debt discount
                                     1,200,000           
      loss on sale or disposal of assets
                                       -100,000 300,000 800,000 800,000   100,000 
      issuance costs related to credit agreement
                                               
      pension and postretirement contributions
                                                
      cash dividends paid to shareholders
                                          -6,200,000 -6,200,000 -6,300,000 -6,300,000  
      dividend paid to the timken company
                                               
      net transfers from/(to) parent and affiliates
                                               
      net cash (used) provided by financing activities
                                          -6,400,000 11,700,000     
      amortization related to convertible notes
                                                
      amortization related to other long-term debt
                                                
      loss on pension settlement
                                                
      issuance costs related to convertible notes
                                       -500,000         
      net transfers to timken and affiliates
                                                
      net cash used by financing activities
                                       -10,500,000 -21,500,000 -16,500,000    -400,000   
      amortization related to long-term financing
                                                
      prepaid expenses
                                         7,000,000 5,000,000 -1,800,000 19,800,000   
      payment on long-term debt
                                         -15,000,000 -5,000,000 -5,000,000 -20,000,000 -20,000,000 
      proceeds from issuance of debt
                                          35,000,000 30,000,000 55,000,000 
      deferred financing costs
                                         -1,500,000       
      accounts receivable, including due from related party
                                          25,800,000 8,600,000 51,400,000 400,000 36,400,000 -25,100,000 
      accounts payable, including due to related party
                                          600,000 -12,900,000 -35,000,000 -23,400,000 -17,900,000 5,600,000 
      other accrued liabilities
                                                
      dividend paid to timken
                                                
      net transfers (to)/from timken and affiliates
                                                
      proceeds from sale of assets
                                           100,000 100,000 200,000   
      net transfers (to) from timken and subsidiaries
                                                
      cash received from timken for settlement of separation
                                               
      net transfers (to) from the timken company and subsidiaries
                                                
      net transfers to parent and subsidiaries
                                             -500,000   
      net transfers from/(to) timken and affiliates
                                                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.